Publication:
Blocking the CCL2-CCR2 axis using CCL2-neutralizing antibody is an effective therapy for hepatocellular cancer in a mouse model

Date

2017

Authors

Teng K.-Y.;Han J.;Zhang X.;Shu-Hao Hsu;He S.;Wani N.A.;Barajas J.M.;Snyder L.A.;Frankel W.L.;Caligiuri M.A.;Jacob S.T.;Yu J.;Ghoshal K.

SHU-HAO HSU

Publisher

American Association for Cancer Research Inc.

URI

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85011655226&doi=10.1158%2f1535-7163.MCT-16-0124&partnerID=40&md5=4aaa019e0f7637be05d38347a9b04a6a
https://scholars.lib.ntu.edu.tw/handle/123456789/467348

Collections

Anatomy and Cell Biology / 解剖學暨細胞生物學研究所